4 Pulmonary Hypertension Clinical Trials in Burbank, CA (2026)

Q: How do I join a clinical trial in Burbank?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Burbank research site will contact you.

Recruiting Pulmonary Hypertension Studies in Burbank

NCT05953090Recruiting

VALOR: Vaginal Atrophy & Long-term Observation of Recovery

Vulvovaginal skin conditions, namely vaginal atrophy, lichen sclerosus, lichen simplex chronicus and lichen planus affecting the female adult population will be treated with a novel gel dressing to te...

Burbank, CA2,000 participantsStratpharma AG

View Study Details

NCT06002828Recruiting

Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors

This study examines the impact of social and genetic factors on outcomes in adolescent and young adult (AYA) cancer survivors of Hodgkin or non-Hodgkin lymphoma. Compared to both older adult and child...

Burbank, CA2,000 participantsECOG-ACRIN Cancer Research Group

View Study Details

NCT06890884Recruiting

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Researchers are looking for ways to treat germinal center B-cell-like diffuse large B-cell lymphoma (GCB DLBCL). DLBCL is a fast-growing blood cancer that affects B-cells. GCB is a type of DLBCL that ...

Burbank, CA594 participantsMerck Sharp & Dohme LLC

View Study Details

NCT03739814Recruiting

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

This phase II trial studies how well inotuzumab ozogamicin and blinatumomab with or without ponatinib work in treating patients with CD22-positive B-lineage acute lymphoblastic leukemia that is newly ...

Burbank, CA84 participantsNational Cancer Institute (NCI)

View Study Details

About Pulmonary Hypertension Clinical Trials in Burbank

Pulmonary hypertension is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. It can lead to heart failure if untreated. Treatment includes vasodilators, endothelin receptor antagonists, and PDE-5 inhibitors.

There are currently 4 pulmonary hypertension clinical trials recruiting participants in Burbank, CA. These studies are seeking a combined 4,678 participants. Research is being sponsored by Stratpharma AG, ECOG-ACRIN Cancer Research Group, Merck Sharp & Dohme LLC and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Hypertension Clinical Trials in Burbank — FAQ

Are there pulmonary hypertension clinical trials in Burbank?

Yes, there are 4 pulmonary hypertension clinical trials currently recruiting in Burbank, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Burbank?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Burbank research site will contact you about next steps.

Are clinical trials in Burbank free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Burbank studies also compensate for your time and travel.

What pulmonary hypertension treatments are being tested?

The 4 active trials in Burbank are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary hypertension.

Data updated July 13, 2026 from ClinicalTrials.gov